Opening Recap
Market Pulse: Wall Street’s volatility dialed up as meme-parade antics collided with drug-market breakthroughs. MYX ripped into the spotlight while Bitcoin’s bounce looked more teasing than a genuine turnaround.
Key Movers: MYX’s stampede—fueled by short-squeeze chatter and whispers of a real structural shift—pulled in every momentum trader scrambling not to miss the next run. Meanwhile, Amphastar and Milestone vaulted into view after FDA approvals lit a fire under lagging biotech names.
Macro & Politics: In D.C., Trump’s push to reclassify marijuana to Schedule III is polished theater, promising tax tweaks but leaving federal prohibition largely intact and Big Pharma happy. The real fight remains with state lawmakers and a Congress brave enough to take on entrenched lobbyists.
What’s Next: Get ready for Fed speakers to set the early tone and scan this morning’s tech and financial earnings whispers—any hawkish slip or surprising beat will dictate the next market leg.
Market Commentary
While everyone’s jacked on the fact that MYX exploded in “Short squeeze or structural shift?” (Ambcrypto.com), they’re overlooking the real loose thread: Bitcoin’s so-called recovery is built on shaky ground, as Decrypt points out. That dead-cat bounce sets up a powder keg if miners and whales bail when sentiment flips. Let that happen and you’ll be left holding the bag—hell of a way to end the year.
Then you’ve got two sides of the same D.C. performance: while Reason lays out how “Trump’s Plan To Reclassify Marijuana Would Leave Federal Prohibition Essentially Untouched,” TheFly.com shows Amphastar and Milestone scoring approvals that perk up biotech. It screams one lesson: regulators hold the keys, and legislative theater gets headlines—don’t ignore who’s really pulling the fucking strings.
Stop chasing after every headline squeeze or dead-cat bounce. Chart your entry with strict stops around those breach levels in MYX or watch Bitcoin sentiment gauges before jumping in. And for Christ’s sake, keep one eye on regulatory reruns—they will matter more than the next Fed whisper.
📈 Breaking Financial News
A significant supply zone around $3.5 has been breached.
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Bitcoin's recent 15% rally was driven by short covering, but a sustained recovery is possible with a short squeeze and uptick in spot demand.
This stock is avoiding the market weakness on Monday. Let's find out why.
The post This ASX 200 stock is charging higher on FDA approval news appeared first on The Motley Fool Australia.
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
The Liquidity Engine Powering Crypto's Comeback
Institutional capital is flooding in while most investors remain completely unaware – creating what could be the buying opportunity of a lifetime. Exposed: Crypto's liquidity backbone set for massive gains – get all details for just $3!
🔍 Market Analysis & Insights
Reclassifying cannabis would acknowledge medical use and ease research, but federal bans and enforcement risks would persist.
Bitcoin is sitting at a crossroads this week, with major analysts outlining sharply divergent short-term paths that all point toward far higher levels once the next move confirms.
Costco downgraded, Dollar General upgraded: Wall Street's top analyst calls
Burlingame, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) — The Global Elderly Care Market is estimated to be valued at USD 1.5 Tn in 2025 and is expected to reach USD 2.7 Tn by 2032, exhibiting a compound annual growth rate (CAGR) of 09.1% from 2025 to 2032. This stron…
Broadcom (AVGO) just reported another monster quarter, then saw its stock take a beating. Shares tanked 11% to nearly $360, erasing over $200 billion in…
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.
💰 Investment Opportunities
Delray Beach, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) — Rapid innovation, expanding clinical pipelines, and rising demand for curative treatments position gene therapy as a transformative growth engine across healthcare markets
The FDA greenlit Pfizer’s Abrysvo RSV vaccine for pregnant women despite its own advisory committee (VRBPAC) warning of insufficient safety data and higher preterm birth risks in clinical trials. Pfizer celebrated the approval as a “milestone,” while Dr. Paul…
Nifty has stabilized near recent highs, consolidating after a rebound from the 25,700 zone. The index faces resistance at 26,050–26,300, with a decisive move above this level potentially leading to a rally towards 26,350–26,500. Immediate support is seen at 2…
Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it may also trigger stricter federal oversight and new legal risks.
This week, high-caps fell below key levels. Here’s a look at how some of your favorite coins fared.
Did you spot this in the Oval Office last week?
When Tim Cook stood in the Oval Office last week, all eyes were on the “unique 24K gold gift” he presented to President Trump. But many viewers missed an even more important moment in that 30-second clip. One that unmistakably singled out what Futurist Eric Fry calls ” possibly the best AI investment anyone could make right now .” Eric believes this little-known partner to Apple could go crazy over the next 12-24 months, potentially leaving well-known AI stocks like Nvidia, Microsoft and Google in the dust. Click to get full details on the company.